E-LIB Suche - Ergebnisse für: Zhong, Wen-zhao

1

PD-L1 expression guidance on sintilimab versus pembrolizuma..:

Maggie Liu, Si-Yang ; Huang, Jie ; Deng, Jia-Yi...
Science Bulletin. 69 (2024) 4 - p. 535-543 , 2024

Link: https://doi.org/10.1016/..

2

Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Fo..:

Lu, Chang ; Wei, Xue-Wu ; Wang, Zhen...
Journal of Thoracic Oncology. 19 (2024) 4 - p. 601-612 , 2024

Link: https://doi.org/10.1016/..

3

Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR..:

Wang, Jie ; Wu, Yi-Long ; Lu, Shun...
JTO Clinical and Research Reports. 5 (2024) 2 - p. 100621 , 2024

Link: https://doi.org/10.1016/..

4

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSC..:

Zhang, Chao ; Sun, Yu-Xuan ; Yi, Ding-Cheng...
Cell Reports Medicine. , 2024

Link: https://doi.org/10.1016/..

5

Redoxhighphenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mut..:

Wei, Xue-Wu ; Lu, Chang ; Zhang, Yi-Chen...
OncoImmunology. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

6

Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non–Sma..:

Zhang, Jia-Tao ; Dong, Song ; Gu, Wei-Quan...
Clinical Lung Cancer. 25 (2024) 1 - p. e1-e4 , 2024

Link: https://doi.org/10.1016/..

7

Acquired DNA damage repairs deficiency-driven immune evolut..:

Tang, Wen-Fang ; Fan, Xiao-Jun ; Bao, Hua...
OncoImmunology. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

8

Dynamic circulating tumor DNA during chemoradiotherapy pred..:

Pan, Yi ; Zhang, Jia-Tao ; Gao, Xuan...
Cancer Cell. 41 (2023) 10 - p. 1763-1773.e4 , 2023

Link: https://doi.org/10.1016/..

9

Impact of preoperative [18F]FDG PET/CT vs. contrast-enhance..:

Lin, Jun-Tao ; Li, Xiang-Meng ; Zhong, Wen-Zhao...
Annals of Nuclear Medicine. 38 (2023) 3 - p. 188-198 , 2023

Link: https://doi.org/10.1007/..

10

ASO Author Reflections: Expression Changes in Programmed De..:

Yang, Xiongwen ; Zhong, Wen-Zhao
Annals of Surgical Oncology. 30 (2023) 12 - p. 7499-7500 , 2023

Link: https://doi.org/10.1245/..

11

Expression Changes in Programmed Death Ligand 1 from Precan..:

Yang, Xiongwen ; Xiao, Yi ; Hu, Hao...
Annals of Surgical Oncology. 30 (2023) 12 - p. 7400-7411 , 2023

Link: https://doi.org/10.1245/..

12

Immune suppressive microenvironment in liver metastases con..:

Deng, Jia-Yi ; Gou, Qing ; Yang, Lingling...
Journal for ImmunoTherapy of Cancer. 11 (2023) 7 - p. e007218 , 2023

Link: https://doi.org/10.1136/..

13

Specific TCR profiles predict clinical outcome of adjuvant ..:

Liu, Si-Yang Maggie ; Chen, Cunte ; Zhang, Yi-Kai...
Biomarker Research. 11 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

14

Lack of incremental value of three-dimensional measurement ..:

Wang, Meng-Min ; Li, Jia-Qi ; Dou, Shi-Hua...
European Journal of Cardio-Thoracic Surgery. 64 (2023) 6 - p. , 2023

Link: https://doi.org/10.1093/..

15

Neoadjuvant nivolumab with or without platinum-doublet chem..:

Liu, Si-Yang ; Dong, Song ; Yang, Xue-Ning...
Signal Transduction and Targeted Therapy. 8 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..